The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a recall for one batch of Deekins Amoxycillin 500mg Capsule, following reports of serious adverse drug reactions.
The affected batch, manufactured by Ecomed Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd, carries the lot number 4C639001.
READ ALSO: NAFDAC workers to begin nationwide strike
According to NAFDAC, the recall is based on reports from a hospital where three patients who were administered the affected batch experienced severe adverse reactions. The drug, amoxicillin, is commonly used to treat bacterial infections such as tonsillitis, pneumonia, and skin infections, among others.
In a statement released on its website, NAFDAC explained that such adverse drug reactions could be life-threatening, potentially leading to hospitalization, prolonged existing hospitalization, significant disability, birth defects, or even death in severe cases. The recalled batch was manufactured in March 2024, with an expiry date of February 2027.
NAFDAC has urged healthcare providers, distributors, and patients to be vigilant and ensure that the affected batch is not distributed, administered, or used. “All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked,” the agency advised.
The agency has called on anyone in possession of the affected batch to immediately discontinue its sale or use and return any remaining stock to the nearest NAFDAC office. NAFDAC also encourages individuals who have used the product or experienced adverse reactions to seek medical attention and report any issues.
Consumers and healthcare professionals are advised to report suspected substandard or falsified medicines to NAFDAC by calling 0800-162-3322 or emailing [email protected]. Additionally, adverse events related to this medication can be reported through NAFDAC’s E-reporting platform available on their website.
